We are live on ! Find out more
SR

Syntax Research Portfolio holdings

AUM $157M
1-Year Est. Return 16.51%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+16.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.04M
Cap. Flow
-$11.9M
Cap. Flow %
-8.48%
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12

Top Buys

1
TMO icon
Thermo Fisher Scientific
TMO
+$2.35M
2
ZTS icon
Zoetis
ZTS
+$2.21M
3
WTW icon
Willis Towers Watson
WTW
+$2.17M
4
PANW icon
Palo Alto Networks
PANW
+$2.16M
5
ACN icon
Accenture
ACN
+$2.03M

Top Sells

1
NTR icon
Nutrien
NTR
+$3.4M
2
AMT icon
American Tower
AMT
+$3.32M
3
NEM icon
Newmont
NEM
+$3.21M
4
COLD icon
Americold
COLD
+$2.6M
5
MRK icon
Merck
MRK
+$2.39M

Sector Composition

1 Technology 19.94%
2 Healthcare 5.03%
3 Industrials 4.92%
4 Financials 4.5%
5 Materials 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KLAC icon
101
KLA
KLAC
$287B
$26K 0.02%
290
– –
NOW icon
102
ServiceNow
NOW
$107B
$25.7K 0.02%
125
– –
CVS icon
103
CVS Health
CVS
$136B
$25.6K 0.02%
371
– –
NVDA icon
104
NVIDIA
NVDA
$5.02T
$25.3K 0.02%
160
– –
IWD icon
105
iShares Russell 1000 Value ETF
IWD
$81.9B
$23.7K 0.02%
122
– –
CBOE icon
106
Cboe Global Markets
CBOE
$29.1B
$23.3K 0.02%
100
– –
GM icon
107
General Motors
GM
$70.1B
$22.9K 0.02%
466
– –
UNP icon
108
Union Pacific
UNP
$178B
$22.8K 0.02%
99
– –
IWP icon
109
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$22.5K 0.02%
162
– –
LOW icon
110
Lowe's Companies
LOW
$121B
$22.2K 0.02%
100
– –
ALC icon
111
Alcon
ALC
$34.4B
$22.1K 0.02%
250
– –
PFE icon
112
Pfizer
PFE
$143B
$21.1K 0.02%
871
– –
UNH icon
113
UnitedHealth
UNH
$384B
$20.9K 0.01%
67
– –
ADBE icon
114
Adobe
ADBE
$93.5B
$20.1K 0.01%
52
– –
HDV
115
iShares Core High Dividend ETF
HDV
$14.2B
$19.3K 0.01%
825
– –
MDLZ icon
116
Mondelez International
MDLZ
$78.8B
$18.1K 0.01%
269
– –
NTR icon
117
Nutrien
NTR
$32.2B
$17.5K 0.01%
300
-60,118
-100% -$3.4M
XOM icon
118
ExxonMobil
XOM
$605B
$16.4K 0.01%
152
– –
T icon
119
AT&T
T
$153B
$15.5K 0.01%
536
– –
C icon
120
Citigroup
C
$221B
$15.2K 0.01%
179
– –
CL icon
121
Colgate-Palmolive
CL
$75.3B
$15K 0.01%
165
– –
USB icon
122
US Bancorp
USB
$99.7B
$14.8K 0.01%
326
– –
MO icon
123
Altria Group
MO
$122B
$14.7K 0.01%
250
– –
VTR icon
124
Ventas
VTR
$46.2B
$14.5K 0.01%
230
– –
KO icon
125
Coca-Cola
KO
$365B
$14.2K 0.01%
200
– –
3 4
5
6 7

Similar funds

BRWM
Blue Rock Wealth Management Winston-Salem, North Carolina $157M AUM 18.03% 1-Year Est. Return
SF
Seros Financial Tempe, Arizona $157M AUM 16.95% 1-Year Est. Return
AC
AlpenGlobal Capital Tahoe City, California $157M AUM
HEM
Henson-Edgewater Management Avon, Ohio $157M AUM
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
TPBG
Turning Point Benefit Group Frederick, Maryland $157M AUM 20.14% 1-Year Est. Return
CFG
Certior Financial Group King Of Prussia, Pennsylvania $157M AUM 12.22% 1-Year Est. Return

Syntax Research's Q2 2025 Portfolio in Review

As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.

  • Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
  • Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
  • Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
  • Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
  • Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
  • Syntax Research opened 7 new positions and closed 12 in Q2 2025.
  • Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.

Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.